Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

1. Borque-Fernando, A.
2. Calleja-Hernández, M.A.
3. Cózar-Olmo, J.M.
4. Gómez-Iturriaga, A.
5. Pérez-Fentes, D.A.
6. Puente-Vázquez, J.
7. Rodrigo-Aliaga, M.
8. Unda, M.
9. Álvarez-Ossorio, J.L.